GE Current launches UVC equipment that can continuously inactivate pathogens

With its abundant lighting and 365DisInFx technology to reduce the spread of bacteria, Daintree company GE Current announced its latest patent pending technology. The goal of this technology is to inactivate viruses in the air and keep lighting at all times. These solutions represent the first line of defense and can fight against a wide range of bacteria including the SARS-CoV-2 virus around the clock.

365DisInFx technology uses the company's existing lighting infrastructure to provide germicidal ultraviolet light sources in places where people gather. Current's patented technology has been proven to significantly reduce common pathogens on the surface, and a number of application tests and end-user trials are underway. It is reported that Current lighting products using 365DisInFx? technology are operating under the restrictions of the IEC 62471 photobiological safety standard.

The traditional disinfection method uses mercury lamps and excimer lamps to emit high-intensity light, with limited design flexibility, and some of these technologies may be harmful to human exposure and the environment. 365DisInFx technology uses an innovative UV-LED solution, which can be easily customized and controlled to adapt to a wider range of spaces and applications.

Current’s design considers easy deployment. The patent-pending germicidal LED lamp will be launched this fall. Its appearance is similar to a smoke detector, compact but unobtrusive, providing continuous UVC radiation, and can be installed on the ceiling.

Current is rapidly expanding its continuous disinfection solutions for hospitals, schools, fitness centers, offices, shops, elderly living facilities, etc. The 365DisInFx technology can be used in Current LED lamps or stand-alone devices to adapt to different environments.

"Our technology can be used in high-risk environments to reduce the potential spread of bacteria and viruses," said Current CEO Manish Bhandari. "Years of responsible research on the use of UV has allowed us to develop a set of solutions. We are committed to adapting to emerging needs and are ready to not only help the healthcare community, but also provide to the wider public need to adopt disinfection strategies."